オルリスタットの世界市場レポート 2025年

オルリスタット市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.4％で41億5,000万米ドルに成長します。予測期間の成長は、肥満治療への医療支出の増加、不健康な食習慣に伴う座りがちなライフスタイル、減量と健康的な生活を促進する政府プログラム、高齢化、店頭シフトへの配合などに起因すると考えられます。予測期間における主要動向には、AIを活用したダイエット計画、遠隔医療サービス、患者に服薬を促し服薬アドヒアランスを追跡する自動化機器、仮想現実・ワークアウト、デジタル治療学などがあります。

オルリスタット市場の成長は、肥満率の増加が牽引すると予想されます。肥満とは、健康に悪影響を及ぼす過剰な体脂肪によって特徴づけられる状態で、一般に体格指数（BMI）30以上で定義されます。肥満の増加には、食生活の乱れ、運動不足、座りがちなライフスタイルなどの要因が関係しています。オルリスタットは、食餌性脂肪の吸収を阻害することにより肥満の管理に役立ち、カロリーを抑えた食事や定期的な運動と並行して使用することで、体重の減少や維持に役立ちます。例えば、世界保健機関（WHO）は2022年3月、世界で10億人以上が肥満の影響を受けていると報告しました。この数字は今後も増加すると予想され、2025年には、成人も幼児も含めて約1億6,700万人が肥満による健康問題の悪化に直面すると予測されています。このような肥満傾向の高まりが、オルリスタットの需要を牽引しています。

オルリスタット市場の各企業は、個人の健康と快適性を高める革新的な減量薬の開発に注力しています。これらの医薬品は、食欲を抑えたり、代謝を促進したり、脂肪の吸収を阻害したりすることで、個人の体重減少を助けるように設計されています。例えば、2023年11月、米国の製薬会社イーライリリー・アンド・カンパニーは、新しい減量薬であるゼップバウンド（チルゼパチド）注射剤のFDA承認を取得しました。ゼップバウンドの特徴は、GIPとGLP-1という2つのインクレチンホルモン受容体を活性化し、体重過多の根本的な原因を標的とする初めての治療として承認されたことです。本剤は、肥満症（BMI >=30kg/m2）または過体重（BMI >=27kg/m2）で、少なくとも1つの体重関連疾患を有する成人の慢性的な体重管理のために、カロリーを抑えた食事と身体活動の増加とともに使用することを意図しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場-金利、インフレ、地政学、新型コロナウイルス感染症、景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のオルリスタット PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のオルリスタット市場：成長率分析
• 世界のオルリスタット市場の実績：規模と成長、2019～2024年
• 世界のオルリスタット市場の予測：規模と成長、2024～2029年、2034年
• 世界のオルリスタット総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のオルリスタット市場：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 120ミリグラム（mg）
• 60ミリグラム（mg）
• 世界のオルリスタット市場：流通チャネル別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院薬局
• オンライン薬局
• 小売薬局
• 世界のオルリスタット市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 減量補助
• その他
• 世界のオルリスタット市場、120ミリグラム（mg）のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 処方薬120mgオルリスタット
• 市販薬（OTC）120mgオルリスタット
• 世界のオルリスタット市場、60ミリグラム（mg）のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 市販薬（OTC）60mgオルリスタット
• 処方薬60mgオルリスタット

第7章 地域別・国別分析

• 世界のオルリスタット市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界のオルリスタット市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• オルリスタット市場：競合情勢
• オルリスタット市場：企業プロファイル
  • Merck & Co. Inc.
  • Sanofi SA
  • GlaxoSmithKline plc
  • Roche Holding AG
  • Novo Nordisk A/S

第31章 その他の大手企業と革新的企業

• Teva Pharmaceutical Industries Ltd.
• Sun Pharmaceutical Industries Ltd.
• Dr. Reddy's Laboratories Ltd.
• Cipla Ltd.
• Intas Pharmaceuticals Ltd.
• Lupin Pharmaceuticals Inc.
• Alkem Laboratories Ltd.
• Torrent Pharmaceuticals Ltd.
• Macleods Pharmaceuticals Ltd.
• Zydus Life
• Emcure Pharmaceuticals Ltd.
• Lannett Company Inc.
• Strides Pharma Science Ltd.
• Indoco Remedies Ltd.
• Wockhardt Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、戦略

• オルリスタット市場、2029年：新たな機会を提供する国
• オルリスタット市場、2029年：新たな機会を提供するセグメント
• オルリスタット市場、2029年：成長戦略
  • 市場動向による戦略
  • 競合の戦略

第36章 付録

Orlistat is a drug designed to assist in weight loss by blocking the absorption of fats from food, which leads to a decrease in calorie intake. It functions by inhibiting the enzyme lipase, which is crucial for digesting dietary fats in the intestine. This medication is usually prescribed for people who are obese or overweight and is most effective when used alongside a low-fat diet and regular physical activity.

Orlistat is available in two main dosages as 120 milligrams (mg) and 60 milligrams (mg). The 120 mg dose is specifically used to support weight loss in obese individuals by preventing the absorption of dietary fats. It is generally taken three times daily with meals that contain fat. This medication can be obtained from various sources, including hospital pharmacies, online pharmacies, and retail pharmacies, and is used primarily for weight management.

The orlistat market research report is one of a series of new reports from The Business Research Company that provides orlistat market statistics, including the orlistat industry's global market size, regional shares, competitors with an orlistat market share, detailed orlistat market segments, market trends and opportunities, and any further data you may need to thrive in the orlistat industry. This orlistat market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The orlistat market size has grown strongly in recent years. It will grow from $3.03 billion in 2024 to $3.24 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to growing awareness of obesity-related health risks, regulatory approvals for orlistat as a prescription medication, the availability of orlistat in lower doses over-the-counter, physician recommendations, and increasing costs of obesity-related healthcare.

The orlistat market size is expected to see strong growth in the next few years. It will grow to $4.15 billion in 2029 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to increasing healthcare spending on obesity treatments, sedentary lifestyles along with unhealthy eating habits, government programs promoting weight loss and healthy living, the aging population, and prescriptions to over-the-counter shift. Major trends in the forecast period include AI-driven diet plans, telehealth services, automated devices that remind patients to take their medication and track adherence, virtual reality workouts, and digital therapeutics.

The growth of the orlistat market is expected to be driven by the increasing rates of obesity. Obesity, a condition marked by excessive body fat that adversely affects health, is commonly defined by a body mass index (BMI) of 30 or higher. The rise in obesity is linked to factors such as poor dietary habits, insufficient physical activity, and sedentary lifestyles. Orlistat aids in managing obesity by blocking the absorption of dietary fats, thus helping in weight reduction and maintenance when used alongside a reduced-calorie diet and regular exercise. For instance, the World Health Organization (WHO) reported in March 2022 that over 1 billion people worldwide were affected by obesity, including 650 million adults, 340 million adolescents, and 39 million children. This number is expected to increase, with projections indicating that by 2025, around 167 million people, including both adults and children, will face worsening health issues due to obesity. This rising prevalence of obesity is driving demand for orlistat.

Companies in the orlistat market are focusing on developing innovative weight loss drugs to enhance personal health and comfort. These drugs are designed to help individuals reduce weight by suppressing appetite, boosting metabolism, or blocking fat absorption. For example, in November 2023, Eli Lilly and Company, a US-based pharmaceutical firm, received FDA approval for Zepbound (tirzepatide) injection, a new weight loss drug. Zepbound is unique as it is the first treatment approved to activate two incretin hormone receptors, GIP and GLP-1, targeting a fundamental cause of excess weight. It is intended for use alongside a reduced-calorie diet and increased physical activity for managing chronic weight in adults with obesity (BMI >=30 kg/m2) or overweight (BMI >=27 kg/m2) who also have at least one weight-related condition.

In August 2023, Eli Lilly and Company acquired Versanis Bio for $1.93 billion. This acquisition expands Lilly's portfolio to include Versanis' leading asset, bimagrumab, which is currently being evaluated in a Phase 2b study, both as a standalone treatment and in combination with semaglutide for overweight and obese adults. Versanis Bio Inc., based in the US, is a biotech company developing treatments for conditions related to overweight and obesity.

Major companies operating in the orlistat market are Merck & Co. Inc., Sanofi SA, GlaxoSmithKline plc, Roche Holding AG, Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Cipla Ltd., Intas Pharmaceuticals Ltd., Lupin Pharmaceuticals Inc., Alkem Laboratories Ltd., Torrent Pharmaceuticals Ltd., Macleods Pharmaceuticals Ltd., Zydus Life, Emcure Pharmaceuticals Ltd., Lannett Company Inc., Strides Pharma Science Ltd., Indoco Remedies Ltd., Wockhardt Ltd., Jubilant Life Sciences Ltd.

North America was the largest region in the orlistat market in 2024. The regions covered in the orlistat market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the orlistat market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The orlistat market consists of sales of xenical, combination supplements, and dietary aids. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Orlistat Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on orlistat market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for orlistat ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The orlistat market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: 120 Milligram (Mg); 60 Milligram(Mg)
• 2) By Distribution Channel: Hospital Pharmacies; Online Pharmacies; Retail Pharmacies
• 3) By Application: Weight-Reducing Aid; Other Applications
• Subsegments:
• 1) By 120 Milligram (Mg): Prescription-Based 120 Mg Orlistat; Over-The-Counter (OTC) 120 Mg Orlistat
• 2) By 60 Milligram (Mg): Over-The-Counter (OTC) 60 Mg Orlistat; Prescription-Based 60 Mg Orlistat
• Companies Mentioned: Merck & Co. Inc.; Sanofi SA; GlaxoSmithKline plc; Roche Holding AG; Novo Nordisk A/S
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Orlistat Market Characteristics

3. Orlistat Market Trends And Strategies

4. Orlistat Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Orlistat Growth Analysis And Strategic Analysis Framework

• 5.1. Global Orlistat PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Orlistat Market Growth Rate Analysis
• 5.4. Global Orlistat Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Orlistat Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Orlistat Total Addressable Market (TAM)

6. Orlistat Market Segmentation

• 6.1. Global Orlistat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 120 Milligram(Mg)
• 60 Milligram(Mg)
• 6.2. Global Orlistat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Online Pharmacies
• Retail Pharmacies
• 6.3. Global Orlistat Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Weight-Reducing Aid
• Other Applications
• 6.4. Global Orlistat Market, Sub-Segmentation Of 120 Milligram (Mg), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Prescription-Based 120 Mg Orlistat
• Over-The-Counter (OTC) 120 Mg Orlistat
• 6.5. Global Orlistat Market, Sub-Segmentation Of 60 Milligram (Mg), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Over-The-Counter (OTC) 60 Mg Orlistat
• Prescription-Based 60 Mg Orlistat

7. Orlistat Market Regional And Country Analysis

• 7.1. Global Orlistat Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Orlistat Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Orlistat Market

• 8.1. Asia-Pacific Orlistat Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Orlistat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Orlistat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Orlistat Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Orlistat Market

• 9.1. China Orlistat Market Overview
• 9.2. China Orlistat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Orlistat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Orlistat Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Orlistat Market

• 10.1. India Orlistat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Orlistat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Orlistat Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Orlistat Market

• 11.1. Japan Orlistat Market Overview
• 11.2. Japan Orlistat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Orlistat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Orlistat Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Orlistat Market

• 12.1. Australia Orlistat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Orlistat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Orlistat Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Orlistat Market

• 13.1. Indonesia Orlistat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Orlistat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Orlistat Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Orlistat Market

• 14.1. South Korea Orlistat Market Overview
• 14.2. South Korea Orlistat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Orlistat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Orlistat Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Orlistat Market

• 15.1. Western Europe Orlistat Market Overview
• 15.2. Western Europe Orlistat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Orlistat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Orlistat Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Orlistat Market

• 16.1. UK Orlistat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Orlistat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Orlistat Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Orlistat Market

• 17.1. Germany Orlistat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Orlistat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Orlistat Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Orlistat Market

• 18.1. France Orlistat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Orlistat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Orlistat Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Orlistat Market

• 19.1. Italy Orlistat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Orlistat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Orlistat Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Orlistat Market

• 20.1. Spain Orlistat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Orlistat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Orlistat Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Orlistat Market

• 21.1. Eastern Europe Orlistat Market Overview
• 21.2. Eastern Europe Orlistat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Orlistat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Orlistat Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Orlistat Market

• 22.1. Russia Orlistat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Orlistat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Orlistat Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Orlistat Market

• 23.1. North America Orlistat Market Overview
• 23.2. North America Orlistat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Orlistat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Orlistat Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Orlistat Market

• 24.1. USA Orlistat Market Overview
• 24.2. USA Orlistat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Orlistat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Orlistat Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Orlistat Market

• 25.1. Canada Orlistat Market Overview
• 25.2. Canada Orlistat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Orlistat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Orlistat Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Orlistat Market

• 26.1. South America Orlistat Market Overview
• 26.2. South America Orlistat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Orlistat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Orlistat Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Orlistat Market

• 27.1. Brazil Orlistat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Orlistat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Orlistat Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Orlistat Market

• 28.1. Middle East Orlistat Market Overview
• 28.2. Middle East Orlistat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Orlistat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Orlistat Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Orlistat Market

• 29.1. Africa Orlistat Market Overview
• 29.2. Africa Orlistat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Orlistat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Orlistat Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Orlistat Market Competitive Landscape And Company Profiles

• 30.1. Orlistat Market Competitive Landscape
• 30.2. Orlistat Market Company Profiles
  • 30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Novo Nordisk A/S Overview, Products and Services, Strategy and Financial Analysis

31. Orlistat Market Other Major And Innovative Companies

• 31.1. Teva Pharmaceutical Industries Ltd.
• 31.2. Sun Pharmaceutical Industries Ltd.
• 31.3. Dr. Reddy's Laboratories Ltd.
• 31.4. Cipla Ltd.
• 31.5. Intas Pharmaceuticals Ltd.
• 31.6. Lupin Pharmaceuticals Inc.
• 31.7. Alkem Laboratories Ltd.
• 31.8. Torrent Pharmaceuticals Ltd.
• 31.9. Macleods Pharmaceuticals Ltd.
• 31.10. Zydus Life
• 31.11. Emcure Pharmaceuticals Ltd.
• 31.12. Lannett Company Inc.
• 31.13. Strides Pharma Science Ltd.
• 31.14. Indoco Remedies Ltd.
• 31.15. Wockhardt Ltd.

32. Global Orlistat Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Orlistat Market

34. Recent Developments In The Orlistat Market

35. Orlistat Market High Potential Countries, Segments and Strategies

• 35.1 Orlistat Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Orlistat Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Orlistat Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer